Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters
In recent weeks, an increase in demand for COVID-19 tests from U.S.
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and…
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests.
Abbott Labs Wins $2.1M Navy Contract For ‘Chemistry Analyzer-Bremerton’
https://sam.gov/opp/4fc7a3dc109e45ebb048a3dbf450b665/view
FDA Warns On Potential False Positive Results With Abbott’s COVID-19 Lab Tests
The FDA has issued a letter to healthcare professionals alerting them to the potential for false-positive results with Abbott Laboratories…
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 13)
Notable Abbott Laboratories Insider Trades $4.14 Million In Company Stock
Michael J Pederson, Senior Vice President at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on September 8, according to a new SEC filing.
Why Biden’s Action Plan Is Bullish For COVID-19 Testing Stocks
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 million rapid point of care and at-home COVID-19 tests.